opioid drugs

How health execs can partner with pharmacists to address opioidsDirector of medication safety and quality for the American Society of Health-System Pharmacists shares how providers can better work with pharmacists to address the opioid epidemic.
Kentucky opioid program drops dispensing by 50%Howard Shaps, MD, senior medical director, WellCare of Kentucky, shares details about the Medicaid insurers’ pilot program designed to fight the opioid epidemic.
Five ways health executives can impact the opioid crisisConsider these five opportunities to help curb one of the biggest public health issues of the year.
493% Increase in Opioid Use Disorder DiagnosesA new BCBS study finds that 21% of insured members filled at least one opioid script in 2015.
Abuse-Deterrent Opioid Rexista Makes Misusers Blue—LiterallyHow one opioid abuse deterrent could make it easy to identify misuse.
Four health systems develop opioid mitigation programsAlternatives to opioids programs emerge as viable tools to mitigate the crisis.
Small Doses: Pharmacy News Featuring Vaccine Skeptics, an Aspirin-Cancer Link, and More
Small Doses: Pharmacy News Featuring Vaccine Skeptics, an Aspirin-Cancer Link, and MoreEasy-to-swallow bits of news from around the world of pharmacy.
CE: Pharmacist Perspective on the CDC Guideline for Prescribing Opioids for Chronic Pain
CE: Pharmacist Perspective on the CDC Guideline for Prescribing Opioids for Chronic Pain
How data analytics combats the opioid epidemicDeaths due to opioid abuse have risen sharply—and show no signs of leveling off. Here’s how data analytics can prevent abuse and diversion.
DEA slashes opioid drug productionThe US Drug Enforcement Administration (DEA) has reduced the amount of almost every Schedule II opiate and opioid medication that may be manufactured in the US by 25% or more.